{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:03:30Z","timestamp":1791169410822,"version":"4.1.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy with a short median survival despite multimodal therapy. FTY720, an immunosuppressive drug approved for the treatment of multiple sclerosis, promotes MCL cell death concurrent with down-modulation of phospho-Akt and cyclin D1 and subsequent cell-cycle arrest. However, the mechanism of FTY720-mediated MCL cell death remains to be fully clarified. In the present study, we show features of autophagy blockage by FTY720 treatment, including accumulation of autolysosomes and increased LC3-II and p62 levels. We also show that FTY720-induced cell death is mediated by lysosomal membrane permeabilization with subsequent translocation of lysosomal hydrolases to the cytosol. FTY720-mediated disruption of the autophagic-lysosomal pathway led to increased levels of CD74, a potential therapeutic target in MCL that is degraded in the lysosomal compartment. This finding provided rationale for examining combination therapy with FTY720 and milatuzumab, an anti-CD74 mAb. Treatment of MCL cell lines and primary tumor cells with FTY720 and milatuzumab resulted in statistically significant enhanced cell death, which was synergistic in blastic variant MCL cell lines. Significant in vivo therapeutic activity of combination treatment was also demonstrated in a preclinical, in vivo model of MCL. These findings support clinical evaluation of this combination in patients with MCL.<\/jats:p>","DOI":"10.1182\/blood-2011-06-363879","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T04:38:35Z","timestamp":1320122315000},"page":"6893-6903","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death"],"prefix":"10.1182","volume":"118","author":[{"given":"Lapo","family":"Alinari","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Mahoney","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Patton","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenguyen","family":"Huynh","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biochemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.","family":"Earl","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeswaran","family":"Mani","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Mao","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Quinion","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Towns","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Shih","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Medicinal Chemistry, The Ohio State University, Columbus, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"Garden State Cancer Center, Center for Molecular Medicine and Immunology, Morris Plains, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie A.","family":"Blum","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Byrd","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natarajan","family":"Muthusamy","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Pr\u00e6torius-Ibba","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biochemistry,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Baiocchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111807200104500_B1","doi-asserted-by":"crossref","first-page":"iv12","DOI":"10.1093\/annonc\/mdj992","article-title":"Mantle cell lymphoma: an update on management.","volume":"17","author":"Zelenetz","year":"2006","journal-title":"Ann Oncol"},{"issue":"1","key":"2019111807200104500_B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.","volume":"117","author":"P\u00e9rez-Gal\u00e1n","year":"2011","journal-title":"Blood"},{"issue":"23","key":"2019111807200104500_B3","first-page":"8226","article-title":"The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.","volume":"63","author":"Mart\u00ednez","year":"2003","journal-title":"Cancer Res"},{"issue":"5","key":"2019111807200104500_B4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.","volume":"108","author":"Rudelius","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2019111807200104500_B5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.","volume":"171","author":"Pham","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"2019111807200104500_B6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"5566","key":"2019111807200104500_B7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"issue":"11","key":"2019111807200104500_B8","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/01.TP.0000121761.02129.A6","article-title":"FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.","volume":"79","author":"Tedesco-Silva","year":"2005","journal-title":"Transplantation"},{"issue":"5","key":"2019111807200104500_B9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.","volume":"362","author":"Cohen","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111807200104500_B10","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1158\/1078-0432.CCR-09-2484","article-title":"FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma.","volume":"16","author":"Liu","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"29","key":"2019111807200104500_B11","doi-asserted-by":"crossref","first-page":"27203","DOI":"10.1074\/jbc.M104684200","article-title":"Invariant chain induces B cell maturation by activating a TAF(II)105-NF-kappaB-dependent transcription program.","volume":"276","author":"Matza","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111807200104500_B12","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1182\/blood-2005-11-4334","article-title":"Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival.","volume":"107","author":"Starlets","year":"2006","journal-title":"Blood"},{"issue":"18","key":"2019111807200104500_B13","doi-asserted-by":"crossref","first-page":"5556s","DOI":"10.1158\/1078-0432.CCR-07-1167","article-title":"CD74: a new candidate target for the immunotherapy of B-cell neoplasms.","volume":"13","author":"Stein","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2019111807200104500_B14","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1182\/blood-2010-08-303354","article-title":"Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.","volume":"117","author":"Alinari","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111807200104500_B15","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/hep.24293","article-title":"Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.","volume":"53","author":"Omar","year":"2011","journal-title":"Hepatology"},{"key":"2019111807200104500_B16","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"International Agency for Research on Cancer","year":"2008"},{"issue":"8","key":"2019111807200104500_B17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.leukres.2006.02.015","article-title":"Mantle cell lymphoma-derived cell lines: unique research tools.","volume":"30","author":"Drexler","year":"2006","journal-title":"Leuk Res"},{"issue":"13","key":"2019111807200104500_B18","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1182\/blood-2008-01-133108","article-title":"Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells.","volume":"112","author":"Lapalombella","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111807200104500_B19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4161\/mabs.1.1.7472","article-title":"Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.","volume":"1","author":"Alinari","year":"2009","journal-title":"MAbs"},{"issue":"7182","key":"2019111807200104500_B20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion.","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"issue":"10","key":"2019111807200104500_B21","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1172\/JCI26390","article-title":"Autophagy in cell death: an innocent convict?","volume":"115","author":"Levine","year":"2005","journal-title":"J Clin Invest"},{"issue":"8","key":"2019111807200104500_B22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4161\/auto.6.8.13614","article-title":"FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy.","volume":"6","author":"Zhang","year":"2010","journal-title":"Autophagy"},{"issue":"7","key":"2019111807200104500_B23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/auto.7.7.15154","article-title":"FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells.","volume":"7","author":"Wallington-Beddoe","year":"2011","journal-title":"Autophagy"},{"issue":"21","key":"2019111807200104500_B24","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J"},{"issue":"3","key":"2019111807200104500_B25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research.","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"issue":"6","key":"2019111807200104500_B26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"issue":"33","key":"2019111807200104500_B27","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.","volume":"282","author":"Pankiv","year":"2007","journal-title":"J Biol Chem"},{"issue":"9","key":"2019111807200104500_B28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0145-2126(02)00013-9","article-title":"Establishment and characterization of a new mantle cell lymphoma cell line, Mino.","volume":"26","author":"Lai","year":"2002","journal-title":"Leuk Res"},{"issue":"5","key":"2019111807200104500_B29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1046\/j.1365-2141.1998.00911.x","article-title":"Establishment and characterization of a mantle cell lymphoma cell line.","volume":"102","author":"Jeon","year":"1998","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111807200104500_B30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-4608(02)00823-3","article-title":"Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model.","volume":"143","author":"M'Kacher","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"2019111807200104500_B31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0145-2126(97)00191-4","article-title":"Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia.","volume":"22","author":"Estrov","year":"1998","journal-title":"Leuk Res"},{"issue":"3","key":"2019111807200104500_B32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/MCB.25.3.1025-1040.2005","article-title":"Inhibition of macroautophagy triggers apoptosis.","volume":"25","author":"Boya","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"8","key":"2019111807200104500_B33","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1158\/0008-5472.CAN-04-3640","article-title":"Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase\/protein kinase B inhibitors.","volume":"65","author":"Takeuchi","year":"2005","journal-title":"Cancer Res"},{"issue":"2","key":"2019111807200104500_B34","doi-asserted-by":"crossref","first-page":"C451","DOI":"10.1152\/ajpcell.00586.2008","article-title":"S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.","volume":"297","author":"Chang","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"2019111807200104500_B35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc1738","article-title":"Lysosomes and autophagy in cell death control.","volume":"5","author":"Kroemer","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2019111807200104500_B36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.imlet.2009.03.006","article-title":"Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cells.","volume":"123","author":"Reich","year":"2009","journal-title":"Immunol Lett"},{"issue":"16","key":"2019111807200104500_B37","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1158\/0008-5472.CAN-05-0850","article-title":"FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.","volume":"65","author":"Yasui","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"2019111807200104500_B38","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI31095","article-title":"FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.","volume":"117","author":"Neviani","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111807200104500_B39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2006-10-053884","article-title":"FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia\/lymphoma.","volume":"111","author":"Liu","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111807200104500_B40","first-page":"1375","article-title":"Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.","volume":"28","author":"Suzuki","year":"1996","journal-title":"Transplant Proc"},{"issue":"2","key":"2019111807200104500_B41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007890-199601270-00006","article-title":"A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation.","volume":"61","author":"Suzuki","year":"1996","journal-title":"Transplantation"},{"issue":"12","key":"2019111807200104500_B42","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1182\/blood-2004-03-0890","article-title":"Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies.","volume":"104","author":"Stein","year":"2004","journal-title":"Blood"},{"key":"2019111807200104500_B43","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1200\/jco.2009.27.15_suppl.8593","article-title":"Dose-escalation trial of milatuzumab (humanized anti-CD74 monoclonal antibody) in multiple myeloma [abstract].","volume":"27","author":"Kaufman","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7137","key":"2019111807200104500_B44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/446745a","article-title":"Cell biology: autophagy and cancer.","volume":"446","author":"Levine","year":"2007","journal-title":"Nature"},{"issue":"2","key":"2019111807200104500_B45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI28833","article-title":"Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma.","volume":"117","author":"Amaravadi","year":"2007","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111807200104500_B46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/bj3590335","article-title":"Sphingosine-induced apoptosis is dependent on lysosomal proteases.","volume":"359","author":"K\u00e5gedal","year":"2001","journal-title":"Biochem J"},{"issue":"10","key":"2019111807200104500_B47","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1084\/jem.20021952","article-title":"Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion.","volume":"197","author":"Boya","year":"2003","journal-title":"J Exp Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/26\/6893\/1343765\/zh805211006893.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/26\/6893\/1343765\/zh805211006893.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T08:03:40Z","timestamp":1639382620000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/26\/6893\/29401\/FTY720-increases-CD74-expression-and-sensitizes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":47,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2011,12,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-06-363879","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]}}}